Azithromycin plus chloroquine

Phase 2Completed

0 views this week 0 watching💤 Quiet

Interest: 35/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Falciparum Malaria

Conditions

Falciparum Malaria

Trial Timeline

Mar 1, 2006 → Feb 1, 2008

NCT ID

NCT00282919

About Azithromycin plus chloroquine

Azithromycin plus chloroquine is a phase 2 stage product being developed by Pfizer for Falciparum Malaria. The current trial status is completed. This product is registered under clinical trial identifier NCT00282919. Target conditions include Falciparum Malaria.

What happened to similar drugs?

3 of 5 similar drugs in Falciparum Malaria were approved

Approved (3) Terminated (0) Active (2)

🔄KLU156 + CoartemNovartisPhase 3

🔄Artemether-lumefantrineNovartisPhase 3

✅Co-artemetherNovartisApproved

✅Flavoquine®, Camoquin® Suspension + Flavoquine®, Camoquin® SuspensionPfizerApproved

✅Artemeter plus lumefantrina vs artesunato plus amodiquinaSanofiApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (2)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01103713	Phase 3	Terminated	Mar 1, 2011	Oct 1, 2013	Asymptomatic Parasitemia In Pregnancy
NCT00282919	Phase 2	Completed	Mar 1, 2006	Feb 1, 2008	Falciparum Malaria

Competing Products

20 competing products in Falciparum Malaria

See all competitors

Product	Company	Stage	Hype Score
(+)-SJ000557733 (SJ733)	Eisai	Phase 2	35
KLU156 + Coartem	Novartis	Phase 3	40
artemether:lumefantrine (2.5 mg:30 mg)	Novartis	Phase 2/3	30
Artemether-lumefantrine (COA566)	Novartis	Phase 2/3	38
INE963	Novartis	Phase 2	35
KAE609 + Piperaquine Phosphate	Novartis	Phase 1	21
KAE609 + SoC (Coartem) + KLU156	Novartis	Phase 2	35
KAF156 + Coartem + Lumefantrine Solid Dispersion Formulation	Novartis	Phase 2	35
Artemether-lumefantrine	Novartis	Phase 3	40
INE963 + KAE609 (Cipargamin) + SoC (Coartem) + KLU156	Novartis	Phase 2	42
KAF156 + LUM-SDF + Coartem	Novartis	Phase 2	35
Co-artemether	Novartis	Approved	43
Azithromycin/Chloroquine + Chloroquine	Pfizer	Phase 2	27
Azithromycin plus Chloroquine + Artemether-lumefantrine	Pfizer	Phase 2/3	38
Azithromycin/Chloroquine + Atovaquone/Proguanil	Pfizer	Phase 2/3	38
Azithromycin/Chloroquine + Sulfadoxine-Pyrimethamine/Chloroquine	Pfizer	Phase 2/3	38
Artesunate (Test) + Artesunate (Comparator)	Pfizer	Phase 1	29
Azithromycin/Chloroquine + Mefloquine	Pfizer	Phase 2/3	38
Flavoquine®, Camoquin® Suspension + Flavoquine®, Camoquin® Suspension	Pfizer	Approved	43
Azithromycin/Chloroquine + Sulfadoxine-Pyrimethamine/Chloroquine	Pfizer	Phase 2/3	30